Materials | Materials | Chemicals | Specialty Chemicals
NASDAQ | Common Stock
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally.
It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets.
The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names.
It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine.
The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010.
Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in theU. S.
Bankruptcy Court for the District of Delaware.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 10, 23 | 0.22 Increased by +164.71% | 0.30 Decreased by -26.67% |
| May 9, 23 | -0.33 Increased by +2.94% | -0.32 Decreased by -3.13% |
| Mar 15, 23 | -0.50 Decreased by -433.33% | -0.27 Decreased by -85.19% |
| Nov 8, 22 | -0.50 Decreased by -354.55% | -0.21 Decreased by -138.10% |
| Aug 9, 22 | -0.34 Decreased by -666.67% | -0.26 Decreased by -30.77% |
| May 10, 22 | -0.34 Increased by +68.52% | -0.30 Decreased by -13.33% |
| Mar 1, 22 | 0.15 Increased by +134.09% | -0.20 Increased by +175.00% |
| Nov 8, 21 | -0.11 Increased by +73.17% | -0.15 Increased by +26.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 23 | 56.08 M Decreased by -2.82% | -201.78 M Decreased by -84.36% | Decreased by -359.78% Decreased by -89.71% |
| Dec 31, 22 | 75.80 M Increased by +17.02% | -150.66 M Decreased by -498.10% | Decreased by -198.76% Decreased by -440.20% |
| Sep 30, 22 | 71.13 M Increased by +48.60% | -167.27 M Decreased by -407.75% | Decreased by -235.17% Decreased by -241.69% |
| Jun 30, 22 | 65.21 M Increased by +24.64% | -108.55 M Decreased by -805.73% | Decreased by -166.47% Decreased by -666.21% |
| Mar 31, 22 | 57.71 M Decreased by -67.37% | -109.44 M Increased by +62.42% | Decreased by -189.65% Decreased by -15.16% |
| Dec 31, 21 | 64.78 M Decreased by -18.77% | 37.84 M Increased by +134.52% | Increased by +58.42% Increased by +142.50% |
| Sep 30, 21 | 47.87 M Increased by +39.72% | -32.94 M Decreased by -42.27% | Decreased by -68.83% Decreased by -1.82% |
| Jun 30, 21 | 52.32 M Increased by +74.36% | 15.38 M Increased by +113.93% | Increased by +29.40% Increased by +107.99% |